All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit Know AML.

The AML Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Introducing

Now you can personalise
your AML Hub experience!

Bookmark content to read later

Select your specific areas of interest

View content recommended for you

Find out more
  TRANSLATE

The AML Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the AML Hub cannot guarantee the accuracy of translated content. The AML Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.

Steering CommitteeAbout UsNewsletterContact
Visit:
ALL Hub

ALL Hub

GvHD Hub

GvHD Hub

Lupus Hub

Lupus Hub

Lymphoma Hub

Lymphoma Hub

MPN Hub

MPN Hub

Multiple Myeloma

Multiple Myeloma Hub

PsOPsA Hub

PsOPsA Hub

LOADING
You're logged in! Click here any time to manage your account or log out.
LOADING
You're logged in! Click here any time to manage your account or log out.
Steering CommitteeAbout UsNewsletterContact
TypesTherapeuticsCongressesTrialsExpert OpinionsDRUG UPDATES
2021-04-09T13:48:39.000Z

What is the outcome of transplantation in fit patients over 64 years?

By Claire Baker, Georgia Scurfield, Maria Kasimati
Featured
Gabriele Magliano
Apr 9, 2021
Share:

Bookmark this article

During the 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), the AML Hub spoke to Gabriele Magliano, Università Cattolica del Sacro Cuore, Rome, IT. We asked, What is the outcome of transplantation in fit patients over 64 years?

What is the outcome of transplantation in fit patients over 64 years?

In this video, Magliano discusses allogeneic hematopoietic stem cell transplantation outcomes for fit patients with AML over the age of 64. He explains that nowadays, age is not the main factor influencing whether patients achieve complete remission, but rather their overall clinical presentation. Magliano outlines the results of recent cohort trials on geriatric patients with AML and remains hopeful for future therapies.

 

More about...
Allo-HSCTEBMT 2021

Your opinion matters

Do you intend to implement next-generation sequencing for measurable residual disease monitoring in MDS patients?
1 vote - 2 days left ...

Related articles

Add bookmark

When is it safe to schedule an allo-HSCT after COVID-19 infection?

During the virtual 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), the AML Hub spoke to Maximilian Christopeit, University Hospital Tübingen,...

Jul 31, 2021
Add bookmark

When is it safe to schedule an allo-HSCT after COVID-19 infection?

During the virtual 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), the AML Hub spoke to...

Jul 31, 2021
Add bookmark

COVID-19 vaccination for hematopoietic stem cell transplant patients

The SARS-CoV-2 pandemic has changed the world over the last year and impacted almost every part of our lives. In particular, patients with hematologic malignancies have been...

May 14, 2021
Add bookmark

COVID-19 vaccination for hematopoietic stem cell transplant patients

The SARS-CoV-2 pandemic has changed the world over the last year and impacted almost every part of our lives. In particular,...

May 14, 2021

Newsletter

Subscribe to get the best content related to AML delivered to your inbox